Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-05-26 @ 6:39 AM
Study NCT ID:
NCT02814656
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2016-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA] | View |
| None | chronic obstructive pulmonary disease | View |
| None | Asthma (in combination with an inhaled corticosteroid [ICS] | View |
| None | alpha-lactose monohydrate | View |
| None | dry powder inhaler | View |
| None | long-acting β2-agonist (LABA) | View |
| None | long-acting muscarinic antagonist (LAMA) | View |
| None | fixed-dose combination (FDC) | View |